HealthcareServices

Interventional Oncology Market Forecast 2026: Where the Industry Is Headed

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the interventional oncology market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Interventional Oncology Market between 2026 and 2030?

The interventional oncology market has seen substantial growth in recent years. This market is expected to expand from $2.72 billion in 2025 to $2.96 billion in 2026, at a compound annual growth rate (CAGR) of 8.8%. The growth observed in the past can be attributed to escalating global cancer incidence rates, the expansion of interventional radiology services, an increasing preference for minimally invasive procedures, enhanced availability of imaging-guided devices, and heightened hospital oncology investments.

The interventional oncology market size is anticipated to experience substantial growth over the next few years, with projections indicating an expansion to $4.14 billion by 2030, at a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period stems from factors such as the increasing adoption of AI-assisted imaging guidance, a rising demand for outpatient cancer treatments, the proliferation of personalized oncology approaches, growing investments in advanced ablation technologies, and an enhanced focus on reducing patient recovery times. Key trends observed within the forecast timeframe encompass a growing uptake of image-guided cancer therapies, the escalating use of minimally invasive ablation procedures, deeper integration of advanced imaging modalities, the widening scope of targeted tumor treatment techniques, and a heightened emphasis on precision oncology.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27318&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Interventional Oncology Market?

The expanding occurrence of cancer is projected to fuel the expansion of the interventional oncology market moving forward. Cancer prevalence signifies the aggregate count of individuals, both those recently identified with cancer and those previously diagnosed, who are currently living with a history of the disease at a given moment. This rise in cancer prevalence stems from lifestyle factors like unhealthy eating habits, tobacco use, drinking alcohol, and exposure to environmental contaminants, which heighten the likelihood of developing different types of cancer. Interventional oncology assists in treating cancer through minimally invasive, targeted treatments that directly address tumors. This approach enhances patient results by minimizing harm to healthy cells and providing quicker recovery periods than conventional treatments. As an illustration, the World Health Organization, an international body based in Switzerland focused on global health policy and public health initiatives, reported in February 2024 that more than 35 million new cancer cases are anticipated in 2050. This represents a 77% surge from the approximately 20 million cases estimated in 2022. Consequently, the expanding incidence of cancer is propelling the development of the interventional oncology market.

How Is The Interventional Oncology Market Organized Into Various Segments?

The interventional oncology market covered in this report is segmented –

1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices

2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided

3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care

4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer

5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions

Subsegments:

1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems

3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices

Which Market Trends Are Opening Growth Opportunities In The Interventional Oncology Market?

Leading firms within the interventional oncology market are concentrating on creating sophisticated products, like microcatheter-based embolization systems, to administer accurate, localized cancer treatment and reduce harm to adjacent healthy tissue. These microcatheter-based embolization systems are defined as medical instruments employing minuscule, adaptable catheters to accurately introduce embolic agents into blood vessels, thereby obstructing or diminishing blood flow, commonly utilized for addressing tumors, vascular abnormalities, or hemorrhage. An example of this innovation is Terumo Corporation, a Japan-based medical device company, which in March 2025 introduced the Occlusafe balloon occlusion catheter, developed from its advanced Balloon-TACE (B-TACE) therapy for treating liver cancer, specifically hepatocellular carcinoma (HCC). This specialized microcatheter utilizes the pressure gradient effect to redirect blood flow and penetrate the microcirculation, facilitating elevated concentrations of therapeutic agents directly at the tumor location and limiting unintended embolization. The goal of this targeted methodology is to enhance clinical results in challenging liver cancer instances by refining the accuracy of drug delivery and providing better visualization during medical procedures.

Who Are The Primary Competitors In The Global Interventional Oncology Market?

Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet SA, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited, Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Medtronic plc, Koninklijke Philips NV, Cook Medical Incorporated

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report

Which Regions Are Poised For Strategic Growth In The Interventional Oncology Market?

North America was the largest region in the interventional oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Interventional Oncology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27318&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Market 2026, By The Business Research Company

Transportation Infrastructure Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/transportation-infrastructure-construction-global-market-report

Residential Building Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/residential-building-construction-global-market-report

Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795